NASDAQ:TKAI
Delisted
Tokai Pharmaceuticals Fund Company Profile
$0.610
+0 (+0%)
At Close: Jan 16, 2018
Information
255 State Street
Boston MA 02109
617-225-4305
Description
Tokai Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. Its lead drug candidate is galeterone, an oral small molecule that is in various clinical trials for the treatment of patients with metastatic castration-resistant prostate cancer. The companys androgen receptor degradation (ARDA) drug discovery program is focused on identifying and developing compounds for ARDA activity. Tokai Pharmaceuticals, Inc. was founded in 2004 and is based in Boston, Massachusetts.